| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |